当前位置:首页 - 行情中心 - 瑞普生物(300119) - 财务分析 - 现金流量表

瑞普生物

(300119)

  

流通市值:50.68亿  总市值:70.60亿
流通股本:3.34亿   总股本:4.65亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金748,563,081.113,420,890,570.732,513,837,702.621,657,858,383.59
  收到的税费返还1,794,143.565,003,379.634,901,396.24,220,572.79
  收到其他与经营活动有关的现金11,244,87377,931,842.16499,351,509.18272,922,537.46
  经营活动现金流入小计761,602,097.673,503,825,792.523,018,090,6081,935,001,493.84
  购买商品、接受劳务支付的现金461,322,813.41,875,217,866.961,412,739,086.4946,628,817.79
  支付给职工以及为职工支付的现金139,289,062.32511,182,431.06394,426,840.27270,042,876.03
  支付的各项税费51,262,720.06164,256,998.13121,765,847.0987,225,175.75
  支付其他与经营活动有关的现金98,377,975.36655,634,877.97883,278,529.02495,730,932.31
  经营活动现金流出小计750,252,571.143,206,292,174.122,812,210,302.781,799,627,801.88
  经营活动产生的现金流量净额11,349,526.53297,533,618.4205,880,305.22135,373,691.96
二、投资活动产生的现金流量:
  收回投资收到的现金485,712,4832,739,125,076.162,086,276,451.161,034,452,256.34
  取得投资收益收到的现金2,646,592.7582,686,982.4576,012,964.0641,496,641.22
  处置固定资产、无形资产和其他长期资产收回的现金净额61,043.66276,375.45185,589.883,131
  处置子公司及其他营业单位收到的现金净额-92,457,782.9892,457,781.98-
  收到的其他与投资活动有关的现金-616,205.4934,902.9834,902.98
  投资活动现金流入小计488,420,119.412,915,162,422.532,254,967,689.981,076,066,931.54
  购建固定资产、无形资产和其他长期资产支付的现金49,547,182.27176,103,686.05112,457,681.9789,215,614.84
  投资支付的现金592,099,6242,466,284,3061,911,673,000868,723,000
  取得子公司及其他营业单位支付的现金-170,550,000170,550,000117,000,000
  投资活动现金流出小计641,646,806.272,812,937,992.052,194,680,681.971,074,938,614.84
  投资活动产生的现金流量净额-153,226,686.86102,224,430.4860,287,008.011,128,316.7
三、筹资活动产生的现金流量:
  吸收投资收到的现金980,0001,130,0006,600,0006,600,000
  其中:子公司吸收少数股东投资收到的现金980,0001,130,0006,600,0006,600,000
  取得借款收到的现金173,517,061.651,186,430,465.2876,364,265.4761,980,000
  收到其他与筹资活动有关的现金1,001,0007,341,497.816,361,779.396,361,779.39
  筹资活动现金流入小计175,498,061.651,194,901,963.01889,326,044.79774,941,779.39
  偿还债务支付的现金106,457,577.61,059,436,851.2776,378,297.4518,698,605.8
  分配股利、利润或偿付利息支付的现金9,226,844.17224,835,731.46215,210,742.11183,903,151.72
  其中:子公司支付给少数股东的股利、利润1,731,090.6557,339,657.5854,829,640.0232,405,091.51
  支付其他与筹资活动有关的现金741,212.69161,095,521.63153,492,385.83152,348,249.17
  筹资活动现金流出小计116,425,634.461,445,368,104.291,145,081,425.34854,950,006.69
  筹资活动产生的现金流量净额59,072,427.19-250,466,141.28-255,755,380.55-80,008,227.3
四、汇率变动对现金及现金等价物的影响-517,499.31-1,817.85196,030.85172,814.38
五、现金及现金等价物净增加额-83,322,232.45149,290,089.7510,607,963.5356,666,595.74
  加:期初现金及现金等价物余额625,515,953.29476,225,863.54476,225,863.54476,225,863.54
  期末现金及现金等价物余额542,193,720.84625,515,953.29486,833,827.07532,892,459.28
补充资料:
  净利润-434,469,249.03-272,063,586.89
  资产减值准备-41,434,927.25-20,375,065.29
  固定资产和投资性房地产折旧-161,951,090.15-83,233,560.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-161,951,090.15-83,233,560.73
  无形资产摊销-50,202,526.96-24,924,978.59
  长期待摊费用摊销-520,261.69-240,992.86
  处置固定资产、无形资产和其他长期资产的损失--3,819,392.15--3,729,955.17
  固定资产报废损失-1,295,915.14-203,060.76
  公允价值变动损失--75,831,147.54--43,282,384.88
  财务费用-35,416,250.71-18,553,122.22
  投资损失--34,221,849.5--32,094,818.1
  递延所得税--17,793,813.96-2,959,919.61
  其中:递延所得税资产减少--9,999,075.03--2,974,736.61
    递延所得税负债增加--7,794,738.93-5,934,656.22
  存货的减少--9,389,028.39--32,408,121.07
  经营性应收项目的减少-1,758,171.48--98,978,935.63
  经营性应付项目的增加--301,818,372.86--82,408,634.92
  其他-1,900,143.11-3,345.25
  现金的期末余额-625,515,953.29-532,892,459.28
  减:现金的期初余额-476,225,863.54-476,225,863.54
  现金及现金等价物的净增加额-149,290,089.75-56,666,595.74
公告日期2026-04-282026-03-312025-10-252025-08-26
审计意见(境内)标准无保留意见
TOP↑